The trial found significant weight loss across all treatment groups, with the highest dose producing the largest effect
Neishaboori N, Wadhwa R, Nogueras-Gonzalez GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG , Skinner HD, Hofstetter WL, Ajani JA
demonstrated that glutamine can directly act on the MTON-S6K1-S6 pathway, and their results revealed that tumor cells take glutamine into the cell through SLC1A5, glutamine supplies energy to the cell and then effluxes through SLC7A5A/SLC38A2
This precision approach reduces trial-and-error treatment, improves adherence, and increases the likelihood of achieving sustained weight loss